Dronedarone

Multaq (dronedarone) is a small molecule pharmaceutical. Dronedarone was first approved as Multaq on 2009-07-01. It is used to treat atrial fibrillation and cardiac arrhythmias in the USA. It has been approved in Europe to treat atrial fibrillation. It is known to target potassium voltage-gated channel subfamily A member 5. Multaq's patents are valid until 2031-06-30 (FDA).